Developer docs
API playgroundTry for free, no card

Search company profiles

Trans Ova Genetics

Full company profile

uuid000c8wm

Namestring
Trans Ova Genetics
Legal namestring
Trans Ova Genetics Corporation
Websiteurl
transova.com
Company typeenum
Private
Founded yearint
1980
Descriptiontext

Trans Ova Genetics is a US-based livestock reproductive biotechnology company founded in 1980 by Dr. David Faber and headquartered in Sioux Center, Iowa. The company provides advanced reproductive technologies (ART) to dairy and beef cattle producers, swine breeders, and small ruminant (sheep and goat) producers, with service offerings spanning In Vitro Fertilization (IVF), conventional Embryo Transfer (ET), sexed semen via reverse-sorting flow cytometry, Somatic Cell Nuclear Transfer (SCNT) cloning, genetic preservation, donor housing, and international embryo and semen export. Its underlying technology stack combines ultrasound-guided oocyte aspiration, laboratory embryo culture achieving 45-50% pregnancy rates with frozen IVF embryos, and proprietary cryopreservation and shipping logistics including the Fresh Ship Program that delivers fresh embryos via FedEx, UPS, or courier to client farms.

Trans Ova operates a multi-tiered distribution model: 14 regional centers across the United States plus an Australian office in Geelong, supported by 50+ satellite locations and the Partnering with Practitioners (PwP) program that trains local veterinarians to perform OPU procedures while Trans Ova handles laboratory work. The company is a wholly-owned subsidiary of URUS Group, a global animal genetics platform, and has expanded its capability footprint through the 2024 acquisition of Recombinetics and Acceligen (gene editing) and the May 2026 acquisition of Vytelle (animal health technology). Sub-brands include ProGentus for economical dairy and beef genetic products and Trans Ova Genetics Advanced Technologies (TOGAT) for cloning and genetic preservation services.

The business model is professional services-based with quote-based pricing determined per engagement; revenue streams include per-procedure charges for IVF and ET, cloning programs, donor housing fees, and export coordination services. Trans Ova serves a customer base ranging from individual small farmers to large enterprise ranch and breeding organizations, with named reference customers across dairy (Wickstrom Jersey Farms, GenoSource, Vander Woude Dairy), beef (Black Diamond Ranch, Express Ranches, Legacy Land & Livestock), and other segments. Distribution and growth are also supported through content marketing (171+ blog articles, podcast, YouTube), youth scholarship programs, and partnerships with organizations such as Reproduction Specialty Group for small ruminant services.

Short descriptiontext

Trans Ova Genetics provides advanced livestock reproductive technologies (IVF, embryo transfer, cloning, sexed semen, genetic preservation) to dairy, beef, swine, and small ruminant producers across a US network of 50+ locations and Trans Ova Australia, operating as a wholly-owned subsidiary of URUS Group.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersSioux Center, United States
HQ citystring
Sioux Center
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices14 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
livestock reproductive technology, bovine embryo transfer, in vitro fertilization services, livestock cloning services, animal genetic preservation
Industry4 codes
1Embryo Transfer (ET) & IVF Services
CodeAFAEAJABPrimaryYes
2Cloning & Advanced Reproductive Technologies Services
CodeAFAEAJALPrimaryNo
3Sexed Semen & Sex Selection Services
CodeAFAEAJAIPrimaryNo
4Dairy Breeding & Genetics (AI, Embryo Transfer)
CodeAFAEACADPrimaryNo
NAICS code1 code
  • Support Activities for Animal Production11521
SIC code2 codes
  • Agricultural Prod-Livestock & Animal Specialties200
  • Agricultural Services700
Product category
Livestock Reproductive Technology Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1In Vitro Fertilization Services
TypeProfessional Services
Description

Professional IVF services including oocyte collection, fertilization, embryo development, and transfer. Services delivered at regional centers, satellite locations, or on-farm.

transova.com
2Embryo Transfer Services
TypeProfessional Services
Description

Conventional in vivo embryo collection and transfer services, including donor preparation, flushing, and recipient synchronization.

transova.com
3Cloning Services
TypeProfessional Services
Description

Full-service livestock cloning including genetic preservation, express tissue banking, and live animal cloning programs for cattle, pigs, goats, sheep, and deer.

transova.com
4Sexed Semen Services
TypeProfessional Services
Description

Gender selection through reverse sorting of frozen semen or processing of fresh semen for use in IVF procedures.

transova.com
5Export Services
TypeProfessional Services
Description

International embryo and semen export services including testing, documentation, and compliance with country-specific requirements.

transova.com
6Donor Housing
TypeProfessional Services
Description

Long and short-term donor animal housing at company facilities with professional care, nutrition, and veterinary management.

transova.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Quote-based professional services
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing is determined through consultation with client services representatives based on specific service requirements, donor characteristics, and facility location selected.

transova.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1ProGentus
Description

A division of Trans Ova Genetics that provides dairy and beef genetic products and services with the goal of creating elite replacement females, offering economical embryo and semen options for producers

transova.com
+1 more record
Core offering1 text field

Trans Ova Genetics is a livestock reproductive technology company that delivers advanced reproductive services to dairy, beef, swine, and small ruminant producers. Its core offerings include In Vitro Fertilization (IVF), Embryo Transfer (ET), sexed semen via reverse sorting, SCNT cloning, genetic preservation, donor housing, and the Fresh Ship Program for embryo logistics. Services are delivered by veterinarians, embryologists, and technicians through a network of regional centers, satellite locations, Partnering with Practitioners sites, and on-farm visits across the U.S. and Australia.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 45-50% pregnancy rate with frozen IVF embryos
+4 more records
Product overview1 text field

Trans Ova Genetics offers a comprehensive suite of advanced reproductive technologies for livestock, primarily serving dairy cattle, beef cattle, small ruminants (sheep and goats), and swine. The core service portfolio centers on In Vitro Fertilization (IVF) and Embryo Transfer (ET), supplemented by sexed semen/gender selection, cloning and genetic preservation, donor housing, and international export services. Services are delivered through a multi-tiered model including corporate/regional centers, satellite locations, and the Partnering with Practitioners (PwP) program. The company also operates ProGentus as a sub-brand for genetic products, and has recently expanded through the acquisition of Vytelle and partnerships with Recombinetics/Acceligen for advanced gene editing capabilities. Supporting infrastructure includes recipient management, the Fresh Ship Program for embryo logistics, and specialized services for small ruminants through Reproduction Specialty Group partnership.

Product and service15 records
1In Vitro Fertilization (IVF)
CategoryAdvanced Reproductive Technology Service
Description

Process of creating embryos from oocytes collected via ultrasound-guided follicular aspiration, fertilized with semen in a Petri dish, and developed in an incubator for seven days before transfer into recipients. Offered for dairy, beef, and small ruminant producers.

2Embryo Transfer (ET)
CategoryAdvanced Reproductive Technology Service
Description

Hormonal treatment of donor cows to cause multiple ovulations, artificial insemination, and non-surgical collection of embryos for transfer into synchronous recipients. Embryos may be cryopreserved for later use. Offered for dairy, beef, and small ruminant producers.

3Sexed Semen / Reverse Sorting
CategoryAdvanced Reproductive Technology Service
Description

Gender selection technology using flow cytometry to separate X and Y chromosome-bearing sperm cells. The reverse sorting process provides approximately 87-90% accuracy of desired sperm cells, enabling producers to produce embryos of the desired gender.

4Fresh Ship Program
CategoryEmbryo Logistics Service
Description

Program allowing fresh IVF embryos to be packaged in culture solution, placed in portable incubators, and shipped via FedEx, UPS, or courier directly to clients' farms for implantation.

5Recipient Options
CategoryRecipient Management Service
Description

Services offering health-tested beef recipients for embryo transfer. Clients can purchase pregnant recipients confirmed at 60 days, or utilize their own recipients.

6Cloning Services
CategoryCloning and Genetic Preservation Service
Description

Somatic Cell Nuclear Transfer (SCNT) cloning technology for producing genetic twins of existing animals. Services include cattle, pigs, goats, sheep, and deer cloning, with over 20+ years of cloning expertise.

7Genetic Preservation (GP)
CategoryCloning and Genetic Preservation Service
Description

Preservation of cells and DNA from elite animals through tissue sampling and cell culture, producing genetically identical cells for long-term storage and future cloning.

8Express Tissue Bank (ETB)
CategoryCloning and Genetic Preservation Service
Description

Economical DNA preservation option where multiple tissue samples are stored intact and can be cultured into a GP cell line if cloning is desired later.

9Donor Housing
CategoryDonor Care Service
Description

Professional donor housing services for bovine and small ruminant donors with 24/7 veterinary access, customized nutrition programs, and regular health monitoring.

10Export Services
CategoryInternational Export Service
Description

Embryo export services to international destinations including Canada, EU, Australia, and China, with dedicated export coordinators managing country-specific testing requirements.

11Swine Services
CategorySwine Reproductive Service
Description

Genetic preservation and cloning services specifically for pigs, helping producers leverage their most valuable pigs for breeding and herd improvement.

12Laparoscopic Artificial Insemination (LAI)
CategorySmall Ruminant Reproductive Service
Description

Advanced reproductive technique for small ruminants allowing precise semen placement directly into the uterus through a coordinated partnership with Reproduction Specialty Group (RSG).

13Small Ruminant Embryo Transfer
CategorySmall Ruminant Reproductive Service
Description

Embryo transfer services for sheep and goats delivered through partnership with Reproduction Specialty Group (RSG), combining specialized veterinary expertise with Trans Ova's reproductive systems.

14Small Ruminant IVF
CategorySmall Ruminant Reproductive Service
Description

In vitro fertilization services for goat and sheep donors through partnership with Reproduction Specialty Group (RSG), enabling producers to create embryos from elite females in a controlled environment.

15ProGentus
CategoryGenetic Products and Services Sub-brand
Description

A division of Trans Ova Genetics providing dairy and beef genetic products and services, offering economical embryo and semen options for producers seeking elite replacement females.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-01
Description

Trans Ova Genetics acquired Lenexa animal health company Vytelle, which had developed technology solutions addressing profitability challenges for cattle producers while increasing milk and meat production. Financial terms were not disclosed.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Trans Ova Genetics Advanced Technologies (TOGAT) integrated Recombinetics and its subsidiary Acceligen to drive cutting-edge advancements in animal genetics through combined expertise in reproductive technologies and gene editing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Subsidiary of Recombinetics focused on Precision Breeding, passionate about addressing animal health challenges and enabling farmers to raise animals with reduced resource consumption through gene editing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership for small ruminant services where RSG leads all on-farm services and scheduling while Trans Ova powers the laboratory and embryo development process for sheep and goat producers.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1CRV
TypeRegional player
Description

CRV is a Dutch-based international cattle genetics cooperative providing AI, embryo transfer, and herd management services to dairy producers globally. Comparable in genetics offering and customer base but primarily European in geographic focus.

TypeDirect peer
Description

Alta Genetics is a global provider of bovine genetics, artificial insemination, and reproductive solutions for dairy and beef producers. Overlapping service portfolio with Trans Ova across conventional reproduction, though less focused on advanced ART like IVF and cloning.

TypeDirect peer
Description

Semex is a Canadian-based bovine genetics cooperative offering AI, embryo transfer, and sexed semen solutions to dairy and beef producers worldwide. Comparable to Trans Ova in genetics product offering and customer base, though with a heavier emphasis on conventional AI rather than advanced ART.

TypeRegional player
Description

Cogent Breeding is a UK-based provider of bovine genetics, sexed semen, and embryo transfer services primarily serving the UK and European markets. Comparable service portfolio to Trans Ova but operating in a different geography with limited US presence.

TypeDirect peer
Description

STgenetics (Sexing Technologies) is a direct competitor offering sexed semen, IVF, and embryo transfer services across dairy and beef cattle, with significant international reach. Highly comparable to Trans Ova's core ART service portfolio and shared customer base of elite dairy and beef producers.

TypeDirect peer
Description

ABS Global is a bovine genetics and reproductive services company serving dairy and beef producers worldwide, now part of Genus plc. Comparable to Trans Ova in providing artificial insemination, embryo transfer, and sexed semen products to commercial cattle operations globally.

TypeDirect peer
Description

Select Sires is a farmer-owned cooperative providing bovine genetics, artificial insemination, and reproductive services to dairy and beef producers across North America. Directly comparable as a cattle-focused genetics and reproductive services provider serving the same producer segments.

TypeDirect peer
Description

Sexing Technologies is the parent of STgenetics and the dominant patent holder of flow cytometry-based sexed semen technology used across the cattle industry. A direct competitor in sexed semen processing and a technology licensor whose IP underpins much of the industry.

TypeBroad incumbent
Description

Genus plc is the parent company of ABS Global and PIC, operating across bovine and porcine genetics globally with both conventional and advanced reproductive services. A larger, publicly-traded incumbent with overlapping capabilities but a much broader portfolio including swine genetics.

10WTA Genetics
TypeEmerging player
Description

WTA Genetics is a US-based cattle embryo transfer and IVF services provider with regional service centers and on-farm capability. A more narrowly-focused emerging peer competing for the same commercial embryo transfer and IVF service dollars in select geographies.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers15 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Trans Ova Genetics

Livestock Reproductive Technology Servicestransova.com

Trans Ova Genetics provides advanced livestock reproductive technologies (IVF, embryo transfer, cloning, sexed semen, genetic preservation) to dairy, beef, swine, and small ruminant producers across a US network of 50+ locations and Trans Ova Australia, operating as a wholly-owned subsidiary of URUS Group.

What Trans Ova Genetics does

Trans Ova Genetics is a US-based livestock reproductive biotechnology company founded in 1980 by Dr. David Faber and headquartered in Sioux Center, Iowa. The company provides advanced reproductive technologies (ART) to dairy and beef cattle producers, swine breeders, and small ruminant (sheep and goat) producers, with service offerings spanning In Vitro Fertilization (IVF), conventional Embryo Transfer (ET), sexed semen via reverse-sorting flow cytometry, Somatic Cell Nuclear Transfer (SCNT) cloning, genetic preservation, donor housing, and international embryo and semen export. Its underlying technology stack combines ultrasound-guided oocyte aspiration, laboratory embryo culture achieving 45-50% pregnancy rates with frozen IVF embryos, and proprietary cryopreservation and shipping logistics including the Fresh Ship Program that delivers fresh embryos via FedEx, UPS, or courier to client farms.

Trans Ova operates a multi-tiered distribution model: 14 regional centers across the United States plus an Australian office in Geelong, supported by 50+ satellite locations and the Partnering with Practitioners (PwP) program that trains local veterinarians to perform OPU procedures while Trans Ova handles laboratory work. The company is a wholly-owned subsidiary of URUS Group, a global animal genetics platform, and has expanded its capability footprint through the 2024 acquisition of Recombinetics and Acceligen (gene editing) and the May 2026 acquisition of Vytelle (animal health technology). Sub-brands include ProGentus for economical dairy and beef genetic products and Trans Ova Genetics Advanced Technologies (TOGAT) for cloning and genetic preservation services.

The business model is professional services-based with quote-based pricing determined per engagement; revenue streams include per-procedure charges for IVF and ET, cloning programs, donor housing fees, and export coordination services. Trans Ova serves a customer base ranging from individual small farmers to large enterprise ranch and breeding organizations, with named reference customers across dairy (Wickstrom Jersey Farms, GenoSource, Vander Woude Dairy), beef (Black Diamond Ranch, Express Ranches, Legacy Land & Livestock), and other segments. Distribution and growth are also supported through content marketing (171+ blog articles, podcast, YouTube), youth scholarship programs, and partnerships with organizations such as Reproduction Specialty Group for small ruminant services.

Trans Ova Genetics firmographics

Firmographics
Name
Trans Ova Genetics
Legal name
Trans Ova Genetics Corporation
Website
https://transova.com
Company type
Private
Founded year
1980
Operating status
Operating
Headcount range
251–500 employees
Short description
Trans Ova Genetics provides advanced livestock reproductive technologies (IVF, embryo transfer, cloning, sexed semen, genetic preservation) to dairy, beef, swine, and small ruminant producers across a US network of 50+ locations and Trans Ova Australia, operating as a wholly-owned subsidiary of URUS Group.
Ownership category
akta.pro rank

Trans Ova Genetics industry classification

Industry
Product category
Livestock Reproductive Technology Services
NAICS
Support Activities for Animal Production (11521)
SIC
Agricultural Prod-Livestock & Animal Specialties (200), Agricultural Services (700)
akta.pro primary industry
Embryo Transfer (ET) & IVF Services (AFAEAJAB)
akta.pro secondary industries
Cloning & Advanced Reproductive Technologies Services (AFAEAJAL), Sexed Semen & Sex Selection Services (AFAEAJAI), Dairy Breeding & Genetics (AI, Embryo Transfer) (AFAEACAD)

Keywords

  • Livestock reproductive technology
  • Bovine embryo transfer
  • In vitro fertilization services
  • Livestock cloning services
  • Animal genetic preservation

Where Trans Ova Genetics is headquartered

Location

Headquarters

HQ city
Sioux Center
HQ country
United States
HQ region
North America

Offices14 records

Markets served

Trans Ova Genetics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. In Vitro Fertilization Services: Professional IVF services including oocyte collection, fertilization, embryo development, and transfer. Services delivered at regional centers, satellite locations, or on-farm.
  2. Embryo Transfer Services: Conventional in vivo embryo collection and transfer services, including donor preparation, flushing, and recipient synchronization.
  3. Cloning Services: Full-service livestock cloning including genetic preservation, express tissue banking, and live animal cloning programs for cattle, pigs, goats, sheep, and deer.
  4. Sexed Semen Services: Gender selection through reverse sorting of frozen semen or processing of fresh semen for use in IVF procedures.
  5. Export Services: International embryo and semen export services including testing, documentation, and compliance with country-specific requirements.
  6. Donor Housing: Long and short-term donor animal housing at company facilities with professional care, nutrition, and veterinary management.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goQuote-based professional services

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Trans Ova Genetics product offering

Product offering

Core offering

Trans Ova Genetics is a livestock reproductive technology company that delivers advanced reproductive services to dairy, beef, swine, and small ruminant producers. Its core offerings include In Vitro Fertilization (IVF), Embryo Transfer (ET), sexed semen via reverse sorting, SCNT cloning, genetic preservation, donor housing, and the Fresh Ship Program for embryo logistics. Services are delivered by veterinarians, embryologists, and technicians through a network of regional centers, satellite locations, Partnering with Practitioners sites, and on-farm visits across the U.S. and Australia.

Product overview

Trans Ova Genetics offers a comprehensive suite of advanced reproductive technologies for livestock, primarily serving dairy cattle, beef cattle, small ruminants (sheep and goats), and swine. The core service portfolio centers on In Vitro Fertilization (IVF) and Embryo Transfer (ET), supplemented by sexed semen/gender selection, cloning and genetic preservation, donor housing, and international export services. Services are delivered through a multi-tiered model including corporate/regional centers, satellite locations, and the Partnering with Practitioners (PwP) program. The company also operates ProGentus as a sub-brand for genetic products, and has recently expanded through the acquisition of Vytelle and partnerships with Recombinetics/Acceligen for advanced gene editing capabilities. Supporting infrastructure includes recipient management, the Fresh Ship Program for embryo logistics, and specialized services for small ruminants through Reproduction Specialty Group partnership.

Differentiator

Problem solved

Functional benefit

Brands

  • ProGentus: A division of Trans Ova Genetics that provides dairy and beef genetic products and services with the goal of creating elite replacement females, offering economical embryo and semen options for producers
  • Trans Ova Australia

Products and services

  • In Vitro Fertilization (IVF) Process of creating embryos from oocytes collected via ultrasound-guided follicular aspiration, fertilized with semen in a Petri dish, and developed in an incubator for seven days before transfer into recipients. Offered for dairy, beef, and small ruminant producers.
  • Embryo Transfer (ET) Hormonal treatment of donor cows to cause multiple ovulations, artificial insemination, and non-surgical collection of embryos for transfer into synchronous recipients. Embryos may be cryopreserved for later use. Offered for dairy, beef, and small ruminant producers.
  • Sexed Semen / Reverse Sorting Gender selection technology using flow cytometry to separate X and Y chromosome-bearing sperm cells. The reverse sorting process provides approximately 87-90% accuracy of desired sperm cells, enabling producers to produce embryos of the desired gender.
  • Fresh Ship Program Program allowing fresh IVF embryos to be packaged in culture solution, placed in portable incubators, and shipped via FedEx, UPS, or courier directly to clients' farms for implantation.
  • Recipient Options Services offering health-tested beef recipients for embryo transfer. Clients can purchase pregnant recipients confirmed at 60 days, or utilize their own recipients.
  • Cloning Services Somatic Cell Nuclear Transfer (SCNT) cloning technology for producing genetic twins of existing animals. Services include cattle, pigs, goats, sheep, and deer cloning, with over 20+ years of cloning expertise.
  • Genetic Preservation (GP) Preservation of cells and DNA from elite animals through tissue sampling and cell culture, producing genetically identical cells for long-term storage and future cloning.
  • Express Tissue Bank (ETB) Economical DNA preservation option where multiple tissue samples are stored intact and can be cultured into a GP cell line if cloning is desired later.
  • Donor Housing Professional donor housing services for bovine and small ruminant donors with 24/7 veterinary access, customized nutrition programs, and regular health monitoring.
  • Export Services Embryo export services to international destinations including Canada, EU, Australia, and China, with dedicated export coordinators managing country-specific testing requirements.
  • Swine Services Genetic preservation and cloning services specifically for pigs, helping producers leverage their most valuable pigs for breeding and herd improvement.
  • Laparoscopic Artificial Insemination (LAI) Advanced reproductive technique for small ruminants allowing precise semen placement directly into the uterus through a coordinated partnership with Reproduction Specialty Group (RSG).
  • Small Ruminant Embryo Transfer Embryo transfer services for sheep and goats delivered through partnership with Reproduction Specialty Group (RSG), combining specialized veterinary expertise with Trans Ova's reproductive systems.
  • Small Ruminant IVF In vitro fertilization services for goat and sheep donors through partnership with Reproduction Specialty Group (RSG), enabling producers to create embryos from elite females in a controlled environment.
  • ProGentus A division of Trans Ova Genetics providing dairy and beef genetic products and services, offering economical embryo and semen options for producers seeking elite replacement females.

Quantifiable outcome

  • 45-50% pregnancy rate with frozen IVF embryos
  • +4 more outcomes

Companies that use Trans Ova Genetics

Customer profile

Named customers15 records

Segments4 records

Ideal customer profiles3 records

Trans Ova Genetics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Trans Ova Genetics partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • VytellecoreStrategic or Co-development Partner · 1 May 2026Trans Ova Genetics acquired Lenexa animal health company Vytelle, which had developed technology solutions addressing profitability challenges for cattle producers while increasing milk and meat production. Financial terms were not disclosed.
  • RecombineticscoreStrategic or Co-development PartnerTrans Ova Genetics Advanced Technologies (TOGAT) integrated Recombinetics and its subsidiary Acceligen to drive cutting-edge advancements in animal genetics through combined expertise in reproductive technologies and gene editing.
  • AcceligencoreStrategic or Co-development PartnerSubsidiary of Recombinetics focused on Precision Breeding, passionate about addressing animal health challenges and enabling farmers to raise animals with reduced resource consumption through gene editing.
  • Reproduction Specialty Group (RSG)coreStrategic or Co-development PartnerPartnership for small ruminant services where RSG leads all on-farm services and scheduling while Trans Ova powers the laboratory and embryo development process for sheep and goat producers.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Trans Ova Genetics competitors and assessment

Company assessment

Regional players

  • CRV: CRV is a Dutch-based international cattle genetics cooperative providing AI, embryo transfer, and herd management services to dairy producers globally. Comparable in genetics offering and customer base but primarily European in geographic focus.
  • Cogent Breeding: Cogent Breeding is a UK-based provider of bovine genetics, sexed semen, and embryo transfer services primarily serving the UK and European markets. Comparable service portfolio to Trans Ova but operating in a different geography with limited US presence.

Direct peers

  • Alta Genetics: Alta Genetics is a global provider of bovine genetics, artificial insemination, and reproductive solutions for dairy and beef producers. Overlapping service portfolio with Trans Ova across conventional reproduction, though less focused on advanced ART like IVF and cloning.
  • Semex: Semex is a Canadian-based bovine genetics cooperative offering AI, embryo transfer, and sexed semen solutions to dairy and beef producers worldwide. Comparable to Trans Ova in genetics product offering and customer base, though with a heavier emphasis on conventional AI rather than advanced ART.
  • STgenetics: STgenetics (Sexing Technologies) is a direct competitor offering sexed semen, IVF, and embryo transfer services across dairy and beef cattle, with significant international reach. Highly comparable to Trans Ova's core ART service portfolio and shared customer base of elite dairy and beef producers.
  • ABS Global: ABS Global is a bovine genetics and reproductive services company serving dairy and beef producers worldwide, now part of Genus plc. Comparable to Trans Ova in providing artificial insemination, embryo transfer, and sexed semen products to commercial cattle operations globally.
  • Select Sires: Select Sires is a farmer-owned cooperative providing bovine genetics, artificial insemination, and reproductive services to dairy and beef producers across North America. Directly comparable as a cattle-focused genetics and reproductive services provider serving the same producer segments.
  • Inguran LLC (Sexing Technologies): Sexing Technologies is the parent of STgenetics and the dominant patent holder of flow cytometry-based sexed semen technology used across the cattle industry. A direct competitor in sexed semen processing and a technology licensor whose IP underpins much of the industry.

Broad incumbents

  • Genus plc: Genus plc is the parent company of ABS Global and PIC, operating across bovine and porcine genetics globally with both conventional and advanced reproductive services. A larger, publicly-traded incumbent with overlapping capabilities but a much broader portfolio including swine genetics.

Emerging players

  • WTA Genetics: WTA Genetics is a US-based cattle embryo transfer and IVF services provider with regional service centers and on-farm capability. A more narrowly-focused emerging peer competing for the same commercial embryo transfer and IVF service dollars in select geographies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Trans Ova Genetics social profiles

Digital presence

Trans Ova Genetics compliance and trust

Trust signal

Compliance1 record

Trans Ova Genetics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Trans Ova Genetics leadership team

Management profile

Number of profiles

Profiles7 records

Trans Ova Genetics subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Trans Ova Genetics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Trans Ova Genetics M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trans Ova Genetics

What does Trans Ova Genetics do?

Trans Ova Genetics is a livestock reproductive technology company that delivers advanced reproductive services to dairy, beef, swine, and small ruminant producers. Its core offerings include In Vitro Fertilization (IVF), Embryo Transfer (ET), sexed semen via reverse sorting, SCNT cloning, genetic preservation, donor housing, and the Fresh Ship Program for embryo logistics. Services are delivered by veterinarians, embryologists, and technicians through a network of regional centers, satellite locations, Partnering with Practitioners sites, and on-farm visits across the U.S. and Australia.

Is Trans Ova Genetics a public or private company?

Trans Ova Genetics is a private company. It is classified as corporate owned and is currently operating.

When was Trans Ova Genetics founded?

Trans Ova Genetics was founded in 1980. It employs 251 to 500 people.

Where is Trans Ova Genetics based?

Trans Ova Genetics is headquartered in Sioux Center, United States, in the North America region.

How does Trans Ova Genetics make money?

Six revenue lines are on record. In Vitro Fertilization Services are the primary driver. The others are embryo Transfer Services, cloning Services, sexed Semen Services, export Services and donor Housing.

Who are Trans Ova Genetics's main competitors?

Regional players on record are CRV and Cogent Breeding. Direct peers are Alta Genetics, Semex, STgenetics, ABS Global, Select Sires and Inguran LLC (Sexing Technologies). Genus plc is listed as a broad incumbent. WTA Genetics is listed as an emerging player.

Does Trans Ova Genetics have an API?

No public API is recorded for Trans Ova Genetics.

What industry is Trans Ova Genetics in?

Trans Ova Genetics's product category is Livestock Reproductive Technology Services. Its primary akta.pro industry code is AFAEAJAB, Embryo Transfer (ET) & IVF Services, with a secondary code of AFAEAJAL, Cloning & Advanced Reproductive Technologies Services. Its NAICS code is 11521 and its SIC code is 200.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American City Business JournalsTrans Ova Genetics acquires Lenexa animal health company VytelleIowa-based Trans Ova Genetics has acquired Lenexa animal health company Vytelle for an undisclosed amount. Vytelle had developed technology solutions addressing a key challenge for cattle producers: maintaining profitability while increasing milk and meat production. Financial terms of the transaction were not disclosed.American City Business JournalsTrans Ova Genetics acquires Lenexa animal health company VytelleTrans Ova Genetics acquired Lenexa-based animal IVF company Vytelle for an undisclosed amount. Vytelle generated $27.4 million in 2024 revenue and captured 10% global market share in five years. The deal expands Trans Ova's reach in bovine genetic advancement.openPR.comBovine Embryo Transfer Market Analysis: Strategic Implications of the Shift from In Vivo to In Vitro Embryo ProductionQYResearch released a market analysis report estimating the global bovine embryo transfer market at US$1.006 billion in 2025, projected to reach US$1.626 billion by 2032 at a 7.2% CAGR, driven by accelerating adoption of advanced reproductive technologies in dairy and beef production. The report identifies a major industry shift from in vivo-derived (IVD) embryo production toward in vitro-produced (IVP) embryos, which now account for over 50% of total transfers in North America, with blastocyst development rates exceeding 40% in commercial settings. Key players profiled include Trans Ova Genetics, GenOvations, Boviteq, ABS Global, Vytelle, SEK Genetics, Paragon, and emerging Chinese companies Qingdao Longming Cattle Industry, Shenzhen Limu Biotechnology, and Inner Mongolia Saikexing.PR NewswirePrecigen Reports Third Quarter 2022 Financial Results and Progress of Clinical ProgramsPrecigen, Inc. reported third-quarter 2022 financial results, achieving a net income of $50.5 million driven by the sale of its subsidiary Trans Ova Genetics and the retirement of $144 million in convertible notes. The company also highlighted clinical progress across its gene and cell therapy pipeline, including completed Phase 1 enrollments for PRGN-2012 and PRGN-3006, and upcoming data presentations at the ASH Annual Meeting.PR NewswirePrecigen Reports Second Quarter and First Half 2022 Financial ResultsPrecigen, Inc. reported second quarter 2022 financial results with total revenues decreasing 24% year-over-year to $2.9 million, while loss from continuing operations improved to $26.1 million compared to $30.9 million in Q2 2021. The company announced the completion of enrollment across multiple Phase 1 clinical studies including PRGN-3006 UltraCAR-T in acute myeloid leukemia, PRGN-3005 in advanced ovarian cancer, PRGN-2012 in recurrent respiratory papillomatosis, and PRGN-2009 in HPV-associated cancers. Additionally, Precigen entered into an agreement to sell its wholly-owned subsidiary Trans Ova Genetics to URUS for $170 million in upfront cash plus up to $10 million earn-out, with closing expected in Q3 2022.PR NewswirePrecigen Enters into Agreement to Divest Non-Healthcare Subsidiary Trans Ova GeneticsPrecigen, Inc. has entered into a definitive agreement to sell its wholly-owned non-healthcare subsidiary Trans Ova Genetics to URUS for $170 million in upfront cash plus up to $10 million earn-out based on 2022-2023 performance. The transaction, expected to close in Q3 2022 pending Hart-Scott-Rodino antitrust clearance, will largely complete Precigen's strategic shift to focus exclusively on healthcare gene and cell therapies. Proceeds from the sale will be used to pay senior convertible notes maturing in July 2023, strengthening the company's balance sheet.PR NewswirePrecigen Reports Fourth Quarter and Full Year 2021 Financial ResultsPrecigen, Inc. reported fourth quarter 2021 financial results with net loss from continuing operations of $25.0 million, improved from $39.7 million in Q4 2020, and full year 2021 net loss of $96.8 million compared to $103.8 million in the prior year. Total revenues increased 25% in Q4 and were comparable year-over-year at $103.9 million, driven by higher demand at non-core businesses Trans Ova and Exemplar, while R&D expenses rose 22% in Q4 due to clinical and preclinical program advancement. The company ended 2021 with $163.7 million in cash and cash equivalents, expected to fund operations well into 2023.PR NewswirePrecigen Reports Third Quarter 2020 and Year-to-Date Financial ResultsPrecigen, Inc. reported third-quarter 2020 financial results showing total revenues of $23.6 million, a 29% increase from the prior year period, driven by collaboration revenue recognition and expanded services from its Trans Ova and Exemplar subsidiaries. The company announced significant clinical pipeline milestones, including FDA clearance for its UltraPorator manufacturing device and the dosing of the first patient in its Phase I/II trial for PRGN-2009 immunotherapy. Despite revenue growth, Precigen reported a net loss of $29.5 million for the quarter, although this represented an improvement from the $49.1 million loss in the same period last year.ThebullvineThe BullvineThe article examines the historical and ongoing importance of dairy cooperatives, genetic innovation, and community support in maintaining profitability for U.S. dairy farmers. It highlights key entities such as Trans Ova Genetics and former co-op structures that secured significant premiums for producers while emphasizing the strategic trade-offs between short-term private contracts and long-term collective bargaining power. The narrative underscores how organizational loyalty and collaborative networks continue to influence market stability and farm viability.ThebullvineThe BullvineThis article reflects on the historical and strategic importance of dairy cooperatives, genetics, and community support in maintaining farm profitability. It highlights Louis Longo's role in negotiating $30 million in premiums for New England farmers in the 1970s and traces the evolution of genetic technologies from Curtis Breeding Service to Trans Ova Genetics. The narrative emphasizes that long-term stability relies on collective bargaining power and community resilience rather than short-term individual gains.